As of May 29, 2025, Poxel SA (POXEL.PA) reports a Gross Margin of 0.05%.
Gross Margin indicates the portion of sales revenue remaining after covering production costs, highlighting operational efficiency.
Historical Trend of Poxel SA's Gross Margin
Over recent years, Poxel SA's Gross Margin has shown significant volatility. The table below summarizes the historical values:
| Date | Gross Margin |
|---|---|
| 2023-12-31 | 0.05% |
| 2022-12-31 | 0.30% |
| 2021-12-31 | 99.56% |
| 2020-12-31 | 100.00% |
| 2019-12-31 | 100.00% |
This gradual decrease highlights how Poxel SA manages its operational efficiency and pricing power over time.
Comparing Poxel SA's Gross Margin to Peers
To better understand Poxel SA's position, it's useful to compare its Gross Margin against industry peers. Below are selected comparisons:
| Company | Gross Margin |
|---|---|
| Poxel SA (POXEL.PA) | 0.05% |
| Biophytis SA (ALBPS.PA) | 7775.20% |
| Nordic Nanovector ASA (NANOV.OL) | 7775.20% |
| Sensorion SA (ALSEN.PA) | 7775.20% |
| XSpray Pharma AB (publ) (XSPRAY.ST) | 2539.90% |
| Gensight Biologics SA (SIGHT.PA) | 188.37% |
Compared to its competitors, Poxel SA's Gross Margin is among the lowest compared to peers, suggesting potential challenges in production costs or pricing strategy.